Literature DB >> 1480401

Functional blindness and visual impairment in older adults from three communities.

M E Salive1, J Guralnik, W Christen, R J Glynn, P Colsher, A M Ostfeld.   

Abstract

PURPOSE: The purpose of this study is to examine the association of sociodemographic factors with functional blindness and visual impairment in an aged population.
METHODS: Three population-based cohorts (East Boston, MA; New Haven, CT; and Iowa and Washington Counties, IA) of persons aged 71 years and older were screened for bilateral functional near and distant vision during an in-home interview in 1988.
RESULTS: Screening was completed by 5335 participants. The prevalence of functional blindness increased with age, from 1% at age 71 to 74 years to 17% in those 90 years of age and older. Functional visual impairment increased from 7% at age 71 to 74 years to 39% in those 90 years of age and older. In multivariate analyses, residence in a nursing home, older age, glaucoma, insulin-requiring diabetes at baseline, East Boston site, history of cataract, and lower 1982 income were independent and significantly associated with both functional blindness and visual impairment. Age and nursing home residence were significantly (P < 0.05) more strongly associated with blindness (odds ratios 4.8 and 6.1, respectively) than they were with visual impairment.
CONCLUSION: Functional blindness and visual impairment are quite prevalent among the oldest old and the institutionalized. The number of affected individuals will increase as the population ages and life expectancy increases. Although visual problems are associated with aging, nursing home residence, health problems, and socioeconomic conditions, they may be readily remediable and may lead to immediate improvements in quality of life.

Entities:  

Mesh:

Year:  1992        PMID: 1480401     DOI: 10.1016/s0161-6420(92)31715-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

Review 1.  Socioeconomic status and blindness.

Authors:  R Dandona; L Dandona
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

2.  Visual acuity measurements in a national sample of British elderly people.

Authors:  J C van der Pols; C J Bates; P V McGraw; J R Thompson; M Reacher; A Prentice; S Finch
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Factors associated with undercorrected refractive errors in an older population: the Blue Mountains Eye Study.

Authors:  S Thiagalingam; R G Cumming; P Mitchell
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 4.  Seeing into the future. Vision and aging.

Authors:  R E Kalina
Journal:  West J Med       Date:  1997-10

5.  Characteristics of older pedestrians who have difficulty crossing the street.

Authors:  J A Langlois; P M Keyl; J M Guralnik; D J Foley; R A Marottoli; R B Wallace
Journal:  Am J Public Health       Date:  1997-03       Impact factor: 9.308

6.  Handgrip strength and cognitive decline in older Mexican Americans.

Authors:  Ana Alfaro-Acha; Soham Al Snih; Mukaila A Raji; Yong-Fang Kuo; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-08       Impact factor: 6.053

7.  Cognitive status, body mass index, and hip fracture in older Hispanic adults.

Authors:  Ana Alfaro-Acha; Glenn V Ostir; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  J Am Geriatr Soc       Date:  2006-08       Impact factor: 5.562

8.  Visual impairment and socioeconomic factors.

Authors:  P M Livingston; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

9.  The scandal of poor medical research. Sloppy use of literature often to blame.

Authors:  R Jones; J Scouller; F Grainger; M Lachlan; S Evans; N Torrance
Journal:  BMJ       Date:  1994-02-26

10.  Relationship between frailty and cognitive decline in older Mexican Americans.

Authors:  Rafael Samper-Ternent; Soham Al Snih; Mukaila A Raji; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  J Am Geriatr Soc       Date:  2008-09-22       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.